Chinese Probe Into GSK—Media Reports and Legal Analysis

by Davis Wright Tremaine LLP
Contact

An unknown number of employees of GlaxoSmithKline (China) Investment Co. Ltd., the local subsidiary of the British multinational corporation GlaxoSmithKline plc. (GSK), were detained on allegations of data fraud and bribery at the end of June.

On July 11, 2013, the Ministry of Public Security (MPS) stated that GSK senior managers had confessed to “serious economic crimes,” including bribery and tax-related violations. Over 30 GSK employees were placed under house arrest and constant surveillance, The Telegraph reported. Four Chinese senior executives, Zhao Hongyan, Liang Hong, Huang Hong, and Zhang Guowei, were arrested and gave full confessions. Steve Nechelput, GSK’s chief financial officer in China, remains in Shanghai under travel restrictions and is being given counsel by the British Foreign Office. Another British national, GSK’s head of emerging markets, Abbas Hussain, apologized for the crimes committed by GSK China employees, and promised to review GSK’s business model and lower drug prices in China. Nearly three weeks after the first allegations, GSK briefed criminal investigators from the Serious Fraud Office (SFO) on its activities in China.

Police reported that GSK employees were suspected of paying bribes to doctors, hospitals, medical associations, and government officials. Employees filed false invoices and used other fraudulent means for personal gain and to acquire bribe funds. Officials estimated that over 3 billion RMB had passed through around 25 different travel agencies or consulting companies since 2007. Some 700 travel agencies and other subcontractors have been investigated in connection with the probe. Gao Feng, head of the economic crimes investigation unit at the MPS, detailed that senior GSK executives were drawn into close relationships with middlemen, who gave them financial and sexual kickbacks in return for business. Gao also hinted that at least four other multinational pharmaceutical companies might also be involved in the investigation as the scope of the anti-bribery probe widens.

Since Gao’s announcement, several sales executives from AstraZeneca, a British-Swedish pharmaceutical company, have been detained by Chinese police. One of the detained is understood to be an American citizen. Company spokespeople declared that the arrests were unrelated to the GSK probe.

GSK response: company pledges to “cooperate fully” with Chinese authorities
Internal GSK investigations following a leak to the Wall Street Journal ended in June, yielding “no evidence of bribery of corruption of doctors or government officials.” After the MPS statement, GSK spokespeople declared that, “These allegations (by the Ministry of Public Security) are shameful…[GSK] will cooperate fully with the Chinese authorities in the investigation of these new allegations.” The company added that it would immediately stop using implicated travel agencies and begin an internal review of all third party agency relationships and past travel agency use.

Under Chinese law, the GSK executives will be formally charged only after the preliminary investigations are completed. A full confession by senior executives might allow them to benefit from leniency measures linked to voluntary disclosure in the resulting trial. 

GSK probe marks largest anti-corruption investigation of a foreign company since 2010, bodes ill for company reputation
This case marks China’s largest bribery investigation of a foreign company since new anti-bribery laws came into effect in 2011 and 2013. It comes in the wake of a series of scandals, and bodes ill for both the company’s future business and its reputation. In 2011, GSK reached a record $3 billion fraud settlement with the U.S. government for aggressive sales and marketing practices. In 2012, GSK fired a number of Chinese employees for expenses manipulation and other abuses, and the head of GSK’s Shanghai research and development facility was let go earlier in June following revelations that he and his assistants had misreported data.

As of July 2, GSK is also facing investigation by the National Reform and Development Council (NRDC)  which has begun examining 27 companies for costs and 33 for pricing, including GSK, Merck & Co., Novartis AG, and Baxter International Inc. The Chinese Food and Drug Administration and the Ministry of Commerce have begun looking into illegal pharmaceutical practices in China, with the CFDA declaring the start of a six-month investigation into bribery, fake drugs, unauthorized medicine sales, and forged receipts.

Implications for international investigations by U.S., U.K., and China
GSK is currently the subject of an ongoing 2010 joint investigation by the U.S. Securities Exchange Commission (SEC) and the Department of Justice (DOJ) into alleged violations of the Foreign Corrupt Practices Act (FCPA) in China. Although GSK is a multinational corporation based in the U.K., its extensive holdings in the United States make it subject to U.S. law as well.

This probe marks the first parallel investigation, or ‘carbon copy prosecution,’ by the Chinese government and the SEC and DOJ of an anti-corruption case. Both countries are subject to WTO anti-corruption criteria and the United Nations Convention against Corruption. Some observers have wondered whether the GSK probe marks the establishment of a more internationalist and active global anti-corruption campaign, which may draw on bribery evidence and admissions generated in DOJ and SEC enforcement actions, or vice versa.

U.S. anti-corruption laws: the FCPA in China
The anti-bribery provision of the United States Foreign Corrupt Practices Act (FCPA), enforced by the DOJ, prohibits U.S. ’issuers,’ ‘domestic concerns,’ and their officers, directors, agents, and shareholders1 from bribing foreign officials with ‘anything of value’ to corruptly influence an official decision or to obtain a business benefit. Prosecutions are based on historically broad definitions, so that a ‘foreign official’ includes government officials as well as employees at government organizations such as state owned enterprises (SOEs) and government hospitals. The term ‘anything of value’ might range from cash or a cash equivalent to loans, travel expenses, charitable donations, commission sharing, and luxury entertainment. The FCPA covers prohibited conduct anywhere in the world by publically traded companies and their officers, directors, employees, and agents, including third party agents, consultants, distributors, and joint-venture partners.

A person or company covered by the FCPA is liable if he/she/it makes a payment to a third party or intermediary while knowing that all or part of the payment will be given to a foreign official.  (“Knowing” is defined very broadly as basically being aware that such a payment will be problematic/raise red flags—and not doing anything about it.) Prohibited payments or activities carried out by third party associates may not constitute grounds for a defense of ignorance by the covered company, because it may be assumed that such company will have appropriately vetted its partners before engaging in business. The DOJ does not insist upon strict liability for the anti-bribery provision.

Penalties may include company fines of up to $2 million, or twice the pecuniary gain from improper payment, while individuals may face fines of up to $100,000, or twice the amount of gross pecuniary gain and/or imprisonment of up to five years. Companies and individuals may be subject to further injunctions, including suspension, or being barred from U.S. government contracts, being barred from receiving export licenses, and being sued in a private cause of action for triple damages under the Racketeer Influenced and Corrupt Organizations Act (RICO).

One exception to the strict anti-bribery provisions is the ‘facilitating payments,’ or ‘grease payment’ exception.2 Grease payments are exempt from FCPA liability.

The ‘Books and Records and Internal Control FCPA provisions, together known as the accounting provisions, are enforced by the SEC and apply to any company listed on a U.S. stock exchange. The Books and Records provision requires the covered entity to keep accurate and detailed records which accurately reflect the transactions and dispositions of the company assets. The internal control provision further requires a covered entity to implement internal accounting controls and to reasonably ensure that transactions i) are executed in accordance with the direction of management, ii) are accurately recorded, and that iii) access to company assets is permitted only with management’s general or specific authorization.

In reality, the accounting provisions may provide a secondary offense for prosecution charges, and violations thereof may include commercial bribes that would typically fall outside of the ‘foreign official’ caveat otherwise needed for liability. Accounting provisions violations may result in fines of up to $25 million for a company, and $5 million and/or imprisonment up to 20 years for culpable individuals. The SEC may require a company to turn over all profits on contracts secured by bribes. Strict liability applies in violations of the accounting provision, so that a company or person is held legally responsible for damages or losses caused by its/his/her acts and omissions, regardless of culpability.

Under the Resource Guide to the U.S. Foreign Corrupt Practices Act, jointly published last November by the DOJ and SEC, the exact meaning of ‘corrupt intent’ remains vague.3 Based on past non-prosecution agreements (NPA) and deferred prosecution agreements (DPA), ‘corrupt intent’ can apply even if the bribe i) does not succeed in influencing the official, ii) the bribe is not ultimately received, or is only promised, iii) the briber does not know the specific identity of the officials, and iv) the payment is passed through a third party, not directly given to an official.

That being said, if there exists a clear corporate policy that defines bribery as wrong, and that policy has been effectively communicated to all employees, any violation of such policy would constitute a knowing, wrongful act. Companies doing business abroad must have a clear anti-corruption corporate compliance policy as well as an effective training program to convey that policy to employees. If evidence of corporate compliance cannot be shown, companies can be held responsible for the illegal payments and actions of their employees or affiliates.

Following last year’s review of the ‘neither admit nor deny’ clause,4 the SEC has determined that the policy will not apply to cases involving (i) parallel criminal convictions, or (ii) NPAs or DPAs that include the admissions or acknowledgements of criminal conduct. Historically, while the DOJ does not allow the ‘neither admit nor deny’ defense, it generally charges only foreign subsidiaries. The SEC, which deals more often with U.S. parent companies, is more flexible in its interpretation of the provision.

Chinese criminal law
Chinese anti-corruption governance is comprised of two main parts: PRC Criminal Law and the Anti-Unfair Competition Law (AUCL), which states that business operators5 in China cannot give ‘money or things,’ (including giving property, promotions, expenses, sponsorships, research expenses, commission, reimbursement of expenses, or kickbacks)6 for the purpose of gaining a competitive advantage. The Communist Party of China (CPC) and the State Council have also issued internal rulings on corruption or bribery of party members and government officials, including the Interim Provisions on the Prohibition of Briberies in Commercial Transactions (Interim Provisions).

While CPC and State Council directives do not create liability for foreign companies, PRC Company Law states that corporate employees who bribe, accept bribes, or embezzle company assets may suffer the confiscation of their illegal income, or sanctions imposed by the company. When such offense encompasses offering money or property to a state functionary for the purpose of securing illegitimate benefits, PRC Criminal Law will also apply.

PRC Criminal Law defines ‘state functionaries’ as individuals of government agencies who are engaged in public service according to the law. SOE employees or individuals of other enterprises or institutions who are engaged in public service, as well as individuals appointed by government agencies, SOEs, and so on to carry out public service, are also considered state functionaries. For the purposes of the Criminal Law, offering bribes to near relatives of state functionaries, who have interests in common with such state functionary, and through third parties, is also illegal.

Company employees and individuals taking advantage of their position to request or accept a ‘relatively large amount of money or goods’ are guilty of accepting bribes as ‘non-state functionaries’ and will be charged as such.

According to the Opinions on Several Issues Concerning Law Application and the Handling of Criminal Commercial Bribery, there are a variety of distinguishing factors between gifts and bribes, including the degree of relationship with the official, value of the good/service given, purpose, timing, and matter of deliver, and whether the recipient has subsequently taken advantage of their position to promote the interests of the giver. In general, bribes are defined by the intention of the giver to get, or the recipient to give, an ‘improper gain.7 Lawful discounts, commissions, and ‘advertising-related gifts of small value’ are all allowed under the AUCL, but said discounts and commissions must be recorded in the company’s financial statements. The promise or proposal of offering a bribe does not constitute an offense under Chinese law.

Under the Interim Provisions, ‘commercial briberies,’ refer to the bribing acts or other means8 of a business offer seeking to sell or purchase commodities from an advantaged position. Acts of bribery include offering rebates which are not recorded in the official company accounts as well as the payment of travel expenses or other benefits. Violations of the Interim Provisions may result in company fines from RMB 10,000 to RMB 200,000, confiscation of illegal earnings, and further potential prosecution under the PRC Criminal Law. Because of complex theories and pre-conditions for charging an entity, Chinese anti-corruption law usually charges individuals.

Charges for giving bribes vary greatly based on the monetary threshold of such bribe or number of personnel to which such bribe is offered, and range from a fixed term imprisonment to life imprisonment and confiscation of property; charges for accepting bribes are generally lower, although state functionaries convicted of accepting ‘serious bribes’ may receive the death penalty. 

U.K. Bribery Act
Accusations by the Chinese investigators and the DOJ and SEC could, if proven, put GSK at risk of prosecution by U.K. authorities under Britain’s severe bribery laws at home.

The U.K. Bribery Act makes it illegal to either pay or receive an advantage to/from another person with the intent to: i) induce a person to perform improperly a relevant function or activity, or ii) reward a person for the improper performance of a relevant function or activity. The Bribery Act applies to the bribery of both public and private persons, and covers U.K. nationals, U.K. residents, and organizations which are either established in the U.K. or conduct business in the U.K. It should be noted that a corporate compliance policy which satisfies the FCPA may not comply with the U.K. adequate procedures guidance published by the SFO. Corporate offense is based on standards of strict liability, barring a defense of adequate procedures.9 Prosecutors do not have to demonstrate prior knowledge, or ‘corrupt intent’ on the part of the company or its officials to charge them under the Bribery Act. Recent changes in the SFO have indicated that self-reporting of violations will no longer predispose the SFO to civil remedies. Facilitating payments, or grease payments, although exempt from the FCPA, are prohibited under the Bribery Act.

It is anticipated that starting in early 2014, the SFO may choose to use DPAs to reach financial settlements with companies. Under a DPA, criminal charges may be brought against a company but not proceeded with, provided that the company complies with agreed terms and conditions. Under the Bribery Act, a company might be sentenced to unlimited fines and, if found guilty of corruption, be banned from public contracts in the U.K. Guilty individuals could face up to 10 years in prison.

The Bribery Act contains some of the strictest laws against corruption, but enforcement has been minimal since the act was passed in 2010. No cases have been brought against international actors so far. Although guidance revisions have indicated a tougher stance towards enforcement, the few cases brought against corporate entities ultimately involved charges under previous laws. Still, the SFO has indicated that a number of cases are currently being investigated, and may lead to prosecutions in the future. 

Final thoughts
After a review of the anti-corruption laws in China, the U.S., and the U.K., it is clear that the allegations against GSK, if true, may result in serious penalties for the multinational company. GSK’s holdings and business are under the jurisdiction of the FCPA, the Bribery Act, and China’s anti-corruption laws. The FCPA only prosecutes against the bribery of foreign officials, although the definition of ‘foreign official’ is more vague than one might imagine, but under Chinese and British laws, GSK senior executives could also be charged for accepting bribes from travel agency middlemen. China and the U.K. also prosecute commercial bribes, while the FCPA only charges for bribes to government officials or other relevant state personnel (see above).

The MPS has declared that the detained GSK executives have made a full confession of their crimes, which may lead to more lenient charges in court. GSK leaders back in the U.K. have also briefed the SFO on their activities in China following the announcement of the Chinese investigation. At the same time, strict revisions to the guidance of both the Bribery Act and the FCPA seem to indicate that cooperation may no longer ensure a more relaxed prosecution in the U.S. or U.K. Companies who find themselves subject to investigations in either of the two countries may need to consider that they can no longer rely on the defense of ‘neither admit nor deny’ for reduced penalties. In the increasingly complicated environment of multinational corporations and foreign subsidiaries, companies must strengthen efforts in due diligence and transparency to ensure that ethics at the corporate level are translated to ground floor business practices, as it is becoming obvious that parent companies will be held responsible for the actions of local employees and partners.

All three legal codes include criminal and civil penalties for the large-scale bribery, records manipulation, and fraud that GSK executives have confessed to, and as the U.S. and China move forward in their first parallel prosecution case, it is certain that the GSK case will set a precedent for the future interplay of multinational anti-corruption law. Because the U.K. Bribery Act and the Chinese laws and provision against bribery are still relatively untested, the GSK case will also prove instrumental in demonstrating how the new legal codes apply to real world cases.

Observers have repeatedly expressed surprise over the extent and severity of the bribes, with some foreign multinational business advisors worrying that the case against GSK represents the targeting of foreign companies in competition with domestic industry, rather than an overarching crackdown on corrupt practices. In either case, companies planning to invest in China in the future must renew their focus on strengthening international compliance policies to ensure that they are not exposed to similar vulnerabilities. Many observers have noted that the crimes that GSK sales personnel and senior executives are accused of are common practice in China’s hyper-competitive pharmaceutical market. However, this case will go some way to defining what practices, common or not, are actually legal in the increasingly stringent anti-corruption laws today.

FOOTNOTES

1 Here, 'issuers’ refer to a company listed on a national securities exchange in the U.S. (either stock or American Depository Receipts), or the company’s stock trades in the over-the-counter market in the U.S. wherein the company is required to file SEC reports; ‘domestic concerns’ are broadly defined as a U.S. person or company.
2 ‘Grease payments’ refer to payments used to expedite a routine government action by a foreign official. Examples of routine government action include: ‘obtaining permits, licenses, or other official documents to qualify a person to do business,’ and scheduling ‘inspections related to transit of goods across country.’ The grease payment exception is intended to apply to ‘largely non-discretionary, ministerial activities performed by mid- or low-level foreign functionaries.’ Relying on the FCPA exemption for grease payments may be problematic because such payments may be illegal in the jurisdiction in which they are made. Failing to properly account for grease payments may also count as a violation of the books and records provision.  
3 See definition of bribery under ‘anti-bribery provision’.
4 The ‘neither admit nor deny’ clause, often used in corporate law as a quick means of resolving regulatory enforcement penalties through the payment of a fine and a settlement agreement, ensures that a defendant is not required to admit to a regulatory authority’s allegations of wrongdoing, but is not permitted to deny the factual allegations set forth in a legal complaint.
5 In the Chinese legal code, business operators are defined as entities and individuals engaged in commercial activities in China, as well as other parties or persons who may impact commercial activities, including commercial entities and for-profit or non-profit entities such as healthcare institutions, schools, etc.
6 The term ‘money or things’ refers to cash; ‘properties or things;’ ‘proprietary interests’ including club membership; cash-equivalent cards; stock options, dividends, or profits without a corresponding investment in the company; reimbursements; and travel expenses; as well as the option to purchase commodities at a price ‘obviously’ lower than market value or selling commodities above market value; payment for non-existent services such as security investments, financial management, or gambling proceeds, etcetera.
7 If the ‘money or things’ given to a state functionary has a value of over RMB 10,000 (a ‘relatively large amount’), it is classified as a ‘kickback’ and automatically connotes illegal or malicious bribing intent.
8 The broadness of the term, ‘other means,’ grants Chinese authorities considerable flexibility in pursing possible commercial bribery actions.
9 If a company has adequate procedures in place designed to prevent persons associated with it from committing bribery, which include competent procedures and targeted risk assessment, it may use the ‘adequate procedures’ defense if a person associated with the company commits an offense.

Comparison of U.K., U.S., and China anti-corruption laws

 

Chinese anti-corruption laws

U.K. Bribery Act

U.S. FCPA

Jurisdiction:

Chinese companies and citizens, agents, third parties, and anyone involved in the bribing situation, including foreign citizens and companies

‘Individuals who have a close connection to the U.K.,’ i.e. U.K. nationals, U.K. residents, and organizations which are either established in the U.K. or conduct business in the U.K.

U.S. companies, their personnel, U.S. citizens, foreign companies listed on a U.S. stock exchange, or otherwise required to file reports with the SEC, foreign companies doing business in the U.S.

Covers:

Public bribery of ‘state functionaries,’ commercial bribery of ‘non-state functionaries’

Public and commercial bribery

Public bribery of ‘foreign officials’

Comprised of:

PRC Company Law

PRC Anti-Unfair Competition Law

PRC Invitation/Bids Submission Law

PRC Criminal Law

Interim Provisions on the Prohibition of Briberies in Commercial Transactions

 

Anti-bribery provision

Books and Records Provision, Internal Control Provision (Accounting Provisions)

Offense:

Bribing another and/or being bribed

Bribing another and/or being bribed

Bribing another

Enforcement:

Commission for Discipline Inspection of the Communist Party

The People’s Procuratorate of the PRC

Ministry of Public Security

State Administration of Industry and Commerce

Serious Fraud Office (SFO)

Department of Justice (DOJ)

Securities and Exchange Commission (SEC)

Self-reporting:

May result in lenient charges

Still subject to prosecution, could gain reduced charges b/c ‘public interest,’ DPA after 2014

May result in NPA or DPA

Corporate Strict Liability:

 

Yes, for failure to prevent bribery (defense: adequate procedures)

No, under anti-bribery provisions;

Yes, under accounting provisions

Facilitating payments:

Illegal; but ‘advertising-related gifts of small value’ may be exempt.

Illegal

OK

Compliance:

 

Adequate Procedures

Corporate compliance and training

Intent vs. Bribe:

Only bribery act is illegal

Both are illegal

Both are illegal (see ‘corporate intent’)

Maximum Criminal Penalty:

6 months to life imprisonment

10 yrs imprisonment and/or an unlimited fine

20 yrs imprisonment

Maximum Civil Penalty:

Confiscation of personal assets

Civil recovery order or civil claims by competitors, etc.

Fines up to $5 million USD (individual) or $25 million USD (company)

 

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Davis Wright Tremaine LLP | Attorney Advertising

Written by:

Davis Wright Tremaine LLP
Contact
more
less

Davis Wright Tremaine LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at www.jdsupra.com) (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at privacy@jdsupra.com.

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to privacy@jdsupra.com. We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to privacy@jdsupra.com.

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at: privacy@jdsupra.com.

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at www.jdsupra.com) (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit legal.hubspot.com/privacy-policy.
  • New Relic - For more information on New Relic cookies, please visit www.newrelic.com/privacy.
  • Google Analytics - For more information on Google Analytics cookies, visit www.google.com/policies. To opt-out of being tracked by Google Analytics across all websites visit http://tools.google.com/dlpage/gaoptout. This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit http://www.aboutcookies.org which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at: privacy@jdsupra.com.

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.